Mycio Wealth Partners, LLC Novo Nordisk A S Transaction History

Mycio Wealth Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$49.46 - $64.78 $415,464 - $544,152	-8,400 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$49.86 - $58.26 $181,989 - $212,649	-3,650 Reduced 30.29%	8,400 $486,000
Q3 2019 Nov 12, 2019	BUY	$47.54 - $53.43 $118,850 - $133,575	2,500 Added 26.18%	12,050 $623,000
Q1 2018 Apr 27, 2018	SELL	$48.49 - $58.14 $190,565 - $228,490	-3,930 Reduced 29.15%	9,550 $470,000
Q4 2017 Jan 31, 2018	SELL	$47.53 - $53.73 $161,602 - $182,682	-3,400 Reduced 20.14%	13,480 $723,000

Q3 2017 Oct 19, 2017	SELL	$41.15 - $49.22 $139,910 - $167,348	-3,400 Reduced 16.77%	16,880 $813,000
Q2 2017 Aug 08, 2017	BUY	N/A	20,280	20,280 $695,000

1,862

309M

5.29M

4.93M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $323B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Mycio Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Mycio Wealth Partners, LLC with notifications on news.